Moleculent: Funding, Investors & Team (Sep 2026)
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular roots of human biology. Creating innovative products to improve human health is their driving force. They anticipate a significant advancement in our comprehension of the molecular underpinnings of human biology within the next decade, which will result in enhanced treatments, diagnostics, and a deeper understanding.
Moleculent has raised $46.0M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Moleculent Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Moleculent Funding Rounds
Moleculent raised $26.0M in a Series A announced in Jun 2024.
1.8 years later, an undisclosed round of $20.0M was announced in Apr 2026.
Moleculent Founders and Leadership Team
Contact details for the Moleculent team: 1 of 1 has an email address on file.
Start 14-day free trial →Moleculent Funding Compared to Other Biotechnology Startups
Moleculent's latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Moleculent in Biotechnology and Solna
Companies Similar to Moleculent
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D…
Moleculent Funding FAQs
What does Moleculent do?
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular roots of human biology. Creating innovative products to improve human health is their driving force. They anticipate a significant advancement in our comprehension of the molecular underpinnings of human biology within the next decade, which will result in enhanced treatments, diagnostics, and a deeper understanding.
How much funding has Moleculent raised?
Moleculent has raised $46.0M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Apr 2026.
When did Moleculent last raise funding?
Moleculent's most recent funding round on record is an undisclosed round of $20.0M, announced in Apr 2026.
Who founded Moleculent?
FundedIQ lists Olle Ericsson (Founder) at Moleculent.
Where is Moleculent headquartered?
Moleculent is based in Solna, Stockholms Lan, Sweden.
How many employees does Moleculent have?
Moleculent is in the 11-50 employee band.
How does Moleculent's funding compare to other Biotechnology startups?
Moleculent's latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Moleculent Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Moleculent is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.